Growing evidence highlights the importance of endogenous anti-infl ammatory mediators in appropriate modulation of infl ammatory responses and suggests that breakdowns in the metabolism of these highly bioactive molecules may underlie disease development ( 1-5 ). One key class of these metabolic regulators is the monoepoxides derived from polyunsaturated fatty acids (MEFAs), synthesized from long-chain omega-3 (n-3) and omega-6 (n-6) PUFAs by cytochrome P450 (CYP450) enzymes ( Fig. 1 ) ( 6 ). Once synthesized, MEFAs can be incorporated into membrane phospholipids or further metabolized by soluble epoxide hydrolase to their less active corresponding diols. In experimental and animal models, MEFAs have potent anti-infl ammatory and vascular protective properties, suggesting potential for development of MEFA-based therapies to target infl ammatory disorders and cardiovascular diseases ( 3, 5, 7 ). However, MEFAs have rarely been measured in humans, and important questions remain regarding their usual physiological concentrations, the interrelationship between different MEFAs derived from different classes of PUFAs, and if and by how much endogenous levels of Abstract Our objective was to assess the dynamics of monoepoxides derived from polyunsaturated fatty acids (MEFAs), and their response to n-3 PUFA supplementation, in the setting of acute tissue injury and infl ammation (cardiac surgery) in humans. Patients (479) undergoing cardiac surgery in three countries were randomized to perioperative fi sh oil (EPA + DHA; 8-10 g over 2-5 days preoperatively, then 2 g/day postoperatively) or placebo (olive oil). Plasma MEFAs derived from n-3 and n-6 PUFAs were measured 2 days postoperatively. Based on serial measures in a subset of the placebo group, levels of all MEFAs declined substantially following surgery (at postoperative day 2), with declines ranging from 37% to 63% ( P < 0.05 each). Compared with placebo at postoperative day 2, levels of EPA-and DHA-derived MEFAs were 40% and 18% higher, respectively ( P Յ 0.004). The n-3 PUFA supplementation did not signifi cantly alter the decline in n-6 PUFA-derived MEFAs. Both enrollment level and changes in plasma phospholipid EPA and DHA were associated with their respective MEFAs at postoperative day 2 ( P < 0.001). Under the acute stress of cardiac surgery, n-3 PUFA supplementation signifi cantly ameliorated the reduction in postoperative n-3 MEFAs, but not n-6 MEFAs, and the degree of increase in n-3 MEFAs related positively to the circulating level of their n-3 PUFA precursors . -Akintoye, E., J.